Delivery Order SPE2DB22D9225-SPE2DB25FR8FS
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,015.29 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300mg dose injections. This firm fixed-price delivery order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a single-unit pharmaceutical procurement with no set-aside designation. The product will be delivered to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, received a delivery order valued at $23.5K from the Defense Logistics Agency (DLA) on June 16, 2025, for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format. This firm fixed-price delivery order, with an ultimate completion date of June 17, 2025, was awarded without set-aside designation and will be performed in Conshohocken, Pennsylvania. The award falls under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $16.8K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300 mg pen injections. The order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and valid through November...
- On June 2, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $9,807.94 to DMS Pharmaceutical Group Inc. for the supply of Cosentyx (secukinumab) 300mg dose-2 pen/ml. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with performance at its Conshohocken, Pennsylvania location. The award carries no set-aside designation, and the delivery order is scheduled for ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,169.67 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order covers the supply of Cosentyx (secukinumab) 300mg dose in 2-pen packages, with performance to be executed in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, allowing the...
- The Defense Logistics Agency awarded a delivery order valued at $13,735.58 to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a pharmaceutical supply requirement with performance taking place in Conshohocken, Pennsylvania. The award was made without set-aside designation to DMS Pharmaceutical Group, a woman-owned small business...
- The Defense Logistics Agency awarded a $19,259.62 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300mg dose-2 pen/ml pharmaceutical products. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, does not utilize a set-aside designation. Performance will be executed in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency awarded a $50,400.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Cosentyx (secukinumab) 300 mg pen 2 mL injections on September 10, 2025, with completion targeted for September 11, 2025. This delivery order was issued without set-aside designation and is being fulfilled from the contractor's place of business in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is supplying this...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,456.01 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for the delivery of Cosentyx Unoready 300 mg pen 2ml pharmaceutical product to a location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,382.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
- SPE2DB22D9225Indefinite Delivery Contract
- SPE2DB22D9225-SPE2DB25FR8FSDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $50,400.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cosentyx (secukinumab) 300 mg pre-filled pens. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the DLA for specialty pharmaceutical products spanning contraceptive devices, oncology treatments, immunosuppressants, and injectable medications. The company's status as a woman-owned small business enables it to compete effectively in federal procurement markets while maintaining a robust portfolio of deliveries to military and federal healthcare systems. This Cosentyx delivery order represents the ongoing fulfillment of the company's core mission to provide targeted pharmaceutical solutions to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.4k | 9/18/25 |